Normal allele: GG
Genetic predisposition to familial non-medullary thyroid cancer.
Polymorphism rs965513 is related to topics like this:
Research and publications:
19198613 Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations.
20350937 The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl.
20505153 A compendium of genome-wide associations for cancer: critical synopsis and reappraisal.
20585100 Genome-wide association studies of cancer.
21858135 Efficient replication of over 180 genetic associations with self-reported medical data.
22267200 Discovery of common variants associated with low TSH levels and thyroid cancer risk.
22493691 Novel associations for hypothyroidism include known autoimmune risk loci.
23327367 Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry.
23344678 Genetic associations with neonatal thyroid-stimulating hormone levels.
24591304 Significant SNPs have limited prediction ability for thyroid cancer.
24723258 Associations between rs965513/rs944289 and papillary thyroid carcinoma risk: a meta-analysis.
25743335 Whole-genome sequence-based analysis of thyroid function.
26206751 TITF1 and TITF2 loci variants indicate significant associations with thyroid cancer.
27109359 Identifying genetically driven clinical phenotypes using linear mixed models.
28049826 MYH9 binds to lncRNA gene PTCSC2 and regulates FOXE1 in the 9q22 thyroid cancer risk locus.
31501191 Genetic Variants Implicate Dual Oxidase-2 in Familial and Sporadic Nonmedullary Thyroid Cancer.
31681970 Clinical implications of GWAS variants associated with differentiated thyroid cancer.